Semaglutide needles are designed for subcutaneous injection, penetrating only the fat layer beneath skin
NAION is marked by sudden, painless vision loss in one eye
Because the medication goes straight into your system, the effects are consistent and predictable, which is why these injections have such strong clinical evidence behind them
In China, as of late 2022, a Phase 3 trial for premenopausal women was underway, and there was a report of the first prescription being dispensed in Hainan province under a special pilot program
Not losing weight on semaglutide can be due to several factors, including improper dosage, lack of adherence to dietary and exercise guidelines, or individual metabolic differences
[23] [24] This pattern reflects the chronic nature of obesity as a disease and suggests that therapy may need to be continued indefinitely for sustained weight management